Global Pediatric Genetic Disease Treatment Market – Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Aug 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Pediatric Genetic Disease Treatment Market By Birth Defects (Cataracts, Cleft Lip or Palate, Congenital Heart Disease, Contractures, Diaphragmatic Hernia, Genital Malformations, Glaucoma, Misshapen Skull, Missing Fingers or Toes, Missing or Incomplete Arms or Legs, Spina Bifida), Chronic Disease (Bleeding Disorders, Childhood Cancers, Kidney or Urinary Tract Disease, Slow Growth or Short Stature, Cystic Fibrosis, Sickle Cell Disease, Thalassemia), Application (Inherited Disorder Testing, Pharmacogenetic Testing (Pgx), Human Leukocyte Antigen (Hla) Testing, Oncology Testing, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Pediatric Genetic Disease Treatment Market

Global pediatric genetic disease treatment market is set to witness a steady CAGR in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Rising cases of genetic disease is the major factor fueling the growth of this market.

Market Definition: Global Pediatric Genetic Disease Treatment Market

Genetic disorders are a kind of a disease which contains different kind of birth defects that are inherited to them through one or both parents. Down syndrome, fetal alcohol syndrome, cystic fibrosis, congenital heart disease etc. are some of the common genetic disorder. Usually pediatric geneticists are those who are specially trained to identify cause and natural history of the disorders. Increasing awareness among population about the genetic disease is the major factor fueling the growth of this market.

Market Drivers

  • Rising cases of cancer such as carcinoma & sarcoma is driving the market growth
  • Increasing consumption of drug and alcohol among youth is another factor contributing in market growth
  • Lack of exercise and improper diet is another factor propelling the market growth
  • Increasing awareness among healthcare professionals regarding genetic disease will also act as a driver for this market

Market Restraints

  • High treatment cost will hinder the growth of this market growth
  • Inadequate reimbursement procedure will also restrain the growth of this market

Segmentation: Global Pediatric Genetic Disease Treatment Market

By Birth Defects

  • Cataracts, Cleft Lip or Palate
  • Congenital Heart Disease
  • Contractures
  • Diaphragmatic Hernia
  • Genital Malformations
  • Glaucoma
  • Misshapen Skull
  • Missing Fingers or Toes
  • Missing or Incomplete Arms or Legs
  • Spina Bifida

By Chronic Disease

  • Bleeding Disorders
  • Childhood Cancers
  • Kidney or Urinary Tract Disease
  • Slow Growth or Short Stature
  • Cystic Fibrosis
  • Sickle Cell Disease
  • Thalassemia

By Application

  • Inherited Disorder Testing

    • Bbloom Syndrome
    • Gaucher’s Disease
    • Tay-Sachs Disease
    • Fragile X-Syndrome

  • Pharmacogenetic Testing (PGX)
  • Human Leukocyte Antigen (HLA) Testing
  • Oncology Testing, Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In January 2019, REGENXBIO Inc. announced that they have received approval from the U.S. Food and Drug Administration for Rare Pediatric Disease Designation to RGX-181. RGX-181 which is designed for the treatment of CLN2 form of batten disease.    It is designed to RGX-181 to use REGENXBIO's NAV AAV9 vector so that they can TPP1 gene directly to the central nervous system. This program is specially designed for the prevention and treatment of rare pediatric disease
  • In October 2018, Ultragenyx Pharmaceutical Inc announced that they have received approval from Brazil’s National Health Surveillance Agency Mepsevii which is designed for the treatment of Mucopolysaccharidosis VII. It is very useful for the children with this disorder. The company is planning to expand them in other regions of the world

Competitive Analysis:

Global pediatric genetic disease treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of pediatric genetic disease treatment market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global pediatric genetic disease treatment market are Abbott, ELITechGroup, PerkinElmer Inc., Quest Diagnostics, AutoGenomics, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, Precipio, Biosystems S.A., Sarepta Therapeutics, BioMarin, GW Pharmaceuticals plc, Vertex Pharmaceuticals Incorporated, Shire, Amgen Inc., Illumina, Inc., Invitae Corporation, Progenity, Inc., Aetna Inc., GeneDx, and others

Research Methodology: Global Pediatric Genetic Disease Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global pediatric genetic disease treatment market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE